Matthew Weinberg Writes for International Clinical Trials (ICT) Magazine
August 16, 2013
In this article CEO Matthew Weinberg discusses the downsides to self-auditing good clinical practice and the need smaller, more proactive audits, on the other hand, can provide a more intelligent analysis.
April 23, 2012
CEO Matthew Weinberg Presents at FDA Clinical Trials Hearing
April 23 - The Weinberg Group CEO, Matthew Weinberg, presented today at FDA’s hearing titled “Modernizing the Regulation of Clinical Trials and Approaches to Good Clinical Practice.” Mr. Weinberg...